Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Condition(s):Pemphigus Foliaceus; Pemphigus VulgarisLast Updated:February 15, 2024Terminated
Hide Studies Not Open or Pending
Condition(s):Pemphigus Foliaceus; Pemphigus VulgarisLast Updated:February 15, 2024Terminated
Condition(s):Prostate Cancer; Prostate Neoplasms; Neoplasms, ProstaticLast Updated:October 31, 2023Active, not recruiting
Condition(s):Chronic Myelogenous Leukemia; Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Hodgkins Lymphoma; Non-Hodgkins LymphomaLast Updated:June 6, 2018Terminated
Condition(s):Cancer; Chemotherapeutic Toxicity; Coronary Artery Disease; Coronary Microvascular DiseaseLast Updated:June 22, 2023Enrolling by invitation
Condition(s):Idiopathic Inflammatory Myopathy; Interstitial Lung DiseaseLast Updated:November 22, 2021Unknown status
Condition(s):Herpes ZosterLast Updated:November 13, 2023Completed
Condition(s):Respiratory DisordersLast Updated:August 31, 2021Completed
Condition(s):Idiopathic Thrombocytopenic PurpuraLast Updated:September 21, 2022Completed
Condition(s):MelanomaLast Updated:June 11, 2015Completed
Condition(s):MiscarriageLast Updated:September 27, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.